image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 1.48
-3.27 %
$ 6.49 M
Market Cap
-0.64
P/E
CASH FLOW STATEMENT
-9.57 M OPERATING CASH FLOW
-29.74%
-221 K INVESTING CASH FLOW
68.10%
14.6 M FINANCING CASH FLOW
914.44%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Intelligent Bio Solutions Inc.
image
Net Income -10.2 M
Depreciation & Amortization 1.21 M
Capital Expenditures -221 K
Stock-Based Compensation 230 K
Change in Working Capital -702 K
Others -258 K
Free Cash Flow -9.79 M

Cash Flow

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017
OPERATING CASH FLOW
Net Income (10.2) (10.7) (8.3) (7.1) (3.2) (7.4) (5.1) (0.3)
Depreciation & Amortization 1.2 1.0 0 0 0 0 0 0
Deferred Income Tax 0 3.7 0 0 0 0 0 0
Stock Based Compensation 0.2 0.3 0 0 0.9 1.9 0 0
Other Operating Activities (0.1) (1.8) 2.5 0.7 0.4 1.9 36.4 K 62.4 K
Change in Working Capital (0.7) 78.9 K 2.4 (4.9) 1.4 (0.1) (0.3) 65.1 K
Cash From Operations (9.6) (7.4) (3.4) (11.3) (0.5) (5.6) (5.4) (0.2)
INVESTING CASH FLOW
Capital Expenditures (0.2) (0.5) (0.4) 0 0 0 0 0
Other Items 0 (0.2) (0.5) 0 14 K 0 0 0
Cash From Investing Activities (0.2) (0.7) (0.9) 0 14 K 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 (0.2) 0 1.4 3.8
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 1.7 (1.1) 0 1.8 0.9 5.3 3.8 (3.4)
Cash From Financing Activities 14.6 1.4 0 23.4 0.7 5.3 5.2 0.3
CHANGE IN CASH
Net Change In Cash 4.8 (6.7) (4.3) 12.1 0.2 (0.2) 0.4 59 K
FREE CASH FLOW
Free Cash Flow (9.8) (7.9) (3.7) (11.3) (0.5) (5.6) (5.4) (0.2)